Stay updated on NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial

Sign up to get notified when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now presents the completed observational study of NOTAL-OCT V2.5 compared with commercial OCT imaging in patients with AMD and diabetic macular edema, including its objectives, eligibility criteria, outcomes, and study dates.
    Difference
    35%
    Check dated 2026-11-07T16:34:16.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T16:46:35.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces website transition updates and says some content may use “Super Intelligence” in place of “Artificial Intelligence.” The study record remains inaccessible.
    Difference
    1%
    Check dated 2026-10-24T19:25:43.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2; the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T19:23:59.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:12:37.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, making the study record inaccessible. The prior study details have been removed and replaced with the standard error page layout.
    Difference
    16%
    Check dated 2026-09-19T22:06:31.000Z thumbnail image

Stay in the know with updates to NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.